Literature DB >> 2536839

Recombinant BALB and Harvey sarcoma viruses with normal proto-ras-coding regions transform embryo cells in culture and cause tumors in mice.

K Cichutek1, P H Duesberg.   

Abstract

The ras genes of BALB and Harvey sarcoma viruses contain point mutations in codon 12 or codons 12 and 59, relative to proto-ras from normal animal and human cells. By in vitro recombination between cloned rat proto-ras and cloned BALB and Harvey sarcoma proviruses, we constructed recombinant proviruses with normal proto-ras-coding regions. These recombinant proviruses transformed mouse 3T3 cells upon transfection. However, when the transforming efficiencies of proviral DNAs were compared after transfection with helper provirus, recombinant proviruses were 2 to 30 times less efficient than the corresponding wild-type proviruses. Recombinant sarcoma viruses isolated from cells transformed by cloned proviral DNA contained the expected normal ras-coding region. They transformed rat embryo cells and induced erythroblastosis and sarcomas in newborn mice as efficiently as wild-type viruses did. We conclude that conversion of normal proto-ras genes to viral ras genes depends on truncation of normal proto-ras regulatory elements and substitution by retroviral (long terminal repeat) promoters and that the transforming function of long terminal repeat-ras genes is enhanced by point mutations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536839      PMCID: PMC247836     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Analysis of viral and somatic activations of the cHa-ras gene.

Authors:  C J Tabin; R A Weinberg
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

2.  Nucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene.

Authors:  E P Reddy; D Lipman; P R Andersen; S R Tronick; S A Aaronson
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Nucleotide sequence of the two rat cellular rasH genes.

Authors:  M Ruta; R Wolford; R Dhar; D Defeo-Jones; R W Ellis; E M Scolnick
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

Review 4.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Biologic and molecular characterization of two newly isolated ras-containing murine leukemia viruses.

Authors:  T N Fredrickson; R R O'Neill; R A Rutledge; T S Theodore; M A Martin; S K Ruscetti; J B Austin; J W Hartley
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

6.  The pathology of tumors and other lesions induced in rodents by virus derived from a rat with Moloney leukemia.

Authors:  F C Chesterman; J J Harvey; R R Dourmashkin; M H Salaman
Journal:  Cancer Res       Date:  1966-08       Impact factor: 12.701

Review 7.  Cancer genes: rare recombinants instead of activated oncogenes (a review).

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Harvey ras genes transform without mutant codons, apparently activated by truncation of a 5' exon (exon -1).

Authors:  K Cichutek; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse.

Authors:  S H Reynolds; S J Stowers; R R Maronpot; M W Anderson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 10.  Evolution of cancer genes as a mutation-driven process.

Authors:  H M Temin
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

View more
  7 in total

1.  Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers.

Authors:  V Y Hua; W K Wang; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  A retroviral promoter is sufficient to convert proto-src to a transforming gene that is distinct from the src gene of Rous sarcoma virus.

Authors:  H Zhou; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.

Authors:  M Souyri; I Vigon; M Charon; P Tambourin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  Transforming function of proto-ras genes depends on heterologous promoters and is enhanced by specific point mutations.

Authors:  A K Chakraborty; K Cichutek; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Development of transforming function during transduction of proto-ras into Harvey sarcoma virus.

Authors:  M Lang; I Treinies; P H Duesberg; R Kurth; K Cichutek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  DNA recombination is sufficient for retroviral transduction.

Authors:  J R Schwartz; S Duesberg; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Unmutated proto-src coding region is tumorigenic if expressed from the promoter of Rous sarcoma virus: implications for the gene-mutation hypothesis of cancer.

Authors:  Y Wu; H Zhou; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.